Updated
Updated · NBC Chicago · Aug 3
GLP-1 Use Reaches 11% of U.S. Adults as Doctors Warn Against Weight-Loss Misuse
Updated
Updated · NBC Chicago · Aug 3

GLP-1 Use Reaches 11% of U.S. Adults as Doctors Warn Against Weight-Loss Misuse

3 articles · Updated · NBC Chicago · Aug 3

Summary

  • 11% of U.S. adults now use GLP-1 drugs for weight loss, up from 3% in 2024, and Gallup says obesity rates have posted a statistically meaningful decline that inversely tracks with rising use.
  • Doctors say that surge is fueling misuse concerns, stressing the drugs should be prescribed for medical need and used under supervision because they are not a short-term fix and weight often returns after stopping.
  • Patients with more than 20% of body weight to lose may benefit more from bariatric surgery than medication alone, surgeons said, with newer procedures less invasive and often covered by major insurance plans.
  • GLP-1s are generally considered safe and effective when doctor-prescribed, but physicians said the best results often come from combining medication with surgery, diet and lifestyle changes.

Insights

As GLP-1 use skyrockets, are patients unknowingly trading obesity for lifelong pharmaceutical dependency and hidden compounding risks?
With bariatric surgeries declining, will the rise of counterfeit and compounded weight-loss drugs trigger a new medical crisis?